Cargando…
Raloxifene is a Female-specific Proteostasis Therapeutic in the Spinal Cord
Several neurodegenerative disorders are characterized by proteasome dysfunctions leading to protein aggregations and pathogenesis. Since we showed that estrogen receptor alpha (ERα) activates the proteasome, drugs able to stimulate ERα in the central nervous system (CNS) could hold potential for the...
Autores principales: | Jenkins, Edmund Charles, Casalena, Gabriella, Gomez, Maria, Zhao, Dazhi, Kenny, Timothy C, Shah, Nagma, Manfredi, Giovanni, Germain, Doris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774777/ https://www.ncbi.nlm.nih.gov/pubmed/33269387 http://dx.doi.org/10.1210/endocr/bqaa221 |
Ejemplares similares
-
Proteasome mapping reveals sexual dimorphism in tissue‐specific sensitivity to protein aggregations
por: Jenkins, Edmund Charles, et al.
Publicado: (2020) -
SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation.
por: Gomez, Maria, et al.
Publicado: (2019) -
Folding Mitochondrial-Mediated Cytosolic Proteostasis Into the Mitochondrial Unfolded Protein Response
por: Jenkins, Edmund Charles, et al.
Publicado: (2021) -
The Proteostasis Network: A Global Therapeutic Target for Neuroprotection after Spinal Cord Injury
por: Whittemore, Scott R., et al.
Publicado: (2022) -
Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)